Via Western blot analysis, we showed that Mcl-1 protein was more weakly expressed in S63845-resistant CTCL cell lines, whereas Bcl-2 and Bcl-xL expression was weakest in the highly sensitive cell line HH. The gene discussed is MCL1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.